Nutrien stock kpis
Adjusted EBITDA by Segment
Nutrien reported adjusted EBITDA by segment of $2.38B in Q2 2026, up 115.5% from Q1 2026 and down 4.2% year over year. The highest value was $4.99B in Q2 2022.
Measures earnings before interest, taxes, depreciation, and amortization for each segment, providing insight into operational performance and cash flow generation.
Potash and nitrogen are reasserting themselves as the company’s cash engines—potash recovered to strong quarterly EBITDA alongside record shipments, and nitrogen’s debottlenecks plus high operating rates have restored mid‑cycle margins, giving management cover to maintain guidance and keep buybacks. Retail is predictably seasonal (bulk of earnings in H1), so Q1 softness is normal but full‑year guidance implies a heavy H1 contribution. Phosphate is the clear risk: volumes rose but margins are squeezed by higher sulfur/ammonia costs, prompting strategic reviews that could reshape the portfolio and near‑term EBITDA; corporate costs remain a steady drag.
NTR Adjusted EBITDA by Segment
| Period | Retail | Potash | Nitrogen | Phospate | Corporate and Others | Eliminations | Total |
|---|---|---|---|---|---|---|---|
| Q2 2026Jun 30, 2026 | $1.13B | $658.00M | $635.00M | $23.00M | -$138.00M | $72.00M | $2.38B |
| Q1 2026Mar 31, 2026 | $108.00M | $578.00M | $482.00M | $57.00M | -$84.00M | -$36.00M | $1.10B |
| Q4 2025Dec 31, 2025 | $311.00M | $445.00M | $521.00M | $107.00M | -$133.00M | $26.00M | $1.28B |
| Q3 2025Sep 30, 2025 | $230.00M | $733.00M | $556.00M | $122.00M | -$114.00M | -$96.00M | $1.43B |
| Q2 2025Jun 30, 2025 | $1.15B | $630.00M | $667.00M | $92.00M | -$104.00M | $52.00M | $2.49B |
| Q1 2025Mar 31, 2025 | $46.00M | $446.00M | $408.00M | $61.00M | -$81.00M | -$28.00M | $852.00M |
| Q4 2024Dec 31, 2024 | $340.00M | $291.00M | $471.00M | $86.00M | -$160.00M | $27.00M | $1.05B |
| Q3 2024Sep 30, 2024 | $151.00M | $555.00M | $355.00M | $89.00M | -$74.00M | -$6.00M | $1.07B |
| Q2 2024Jun 30, 2024 | $1.13B | $472.00M | $594.00M | $88.00M | -$121.00M | $74.00M | $2.23B |
| Q1 2024Mar 31, 2024 | $77.00M | $530.00M | $464.00M | $121.00M | -$101.00M | -$36.00M | $1.05B |
| Q4 2023Dec 31, 2023 | $229.00M | $463.00M | $391.00M | $130.00M | -$117.00M | -$21.00M | $1.07B |
| Q3 2023Sep 30, 2023 | $197.00M | $611.00M | $294.00M | $90.00M | -$77.00M | -$31.00M | $1.08B |
| Q2 2023Jun 30, 2023 | $1.07B | $654.00M | $569.00M | $113.00M | -$60.00M | $135.00M | $2.48B |
| Q1 2023Mar 31, 2023 | -$34.00M | $676.00M | $676.00M | $137.00M | -$13.00M | -$21.00M | $1.42B |
| Q4 2022Dec 31, 2022 | $391.00M | $958.00M | $841.00M | $28.00M | -$180.00M | $57.00M | $2.10B |
| Q3 2022Sep 30, 2022 | $235.00M | $1.38B | $855.00M | $143.00M | -$94.00M | -$50.00M | $2.47B |
| Q2 2022Jun 30, 2022 | $1.43B | $2.03B | $1.24B | $184.00M | -$58.00M | $173.00M | $4.99B |
| Q1 2022Mar 31, 2022 | $240.00M | $1.41B | $995.00M | $239.00M | -$66.00M | -$199.00M | $2.62B |
| Q4 2021Dec 31, 2021 | $442.00M | $1.05B | $921.00M | $196.00M | -$150.00M | $1.00M | $2.46B |
| Q3 2021Sep 30, 2021 | $291.00M | $808.00M | $532.00M | $135.00M | -$42.00M | -$82.00M | $1.64B |
| Q2 2021Jun 30, 2021 | $1.10B | $495.00M | $555.00M | $112.00M | -$68.00M | $24.00M | $2.21B |
| Q1 2021Mar 31, 2021 | $109.00M | $380.00M | $300.00M | $97.00M | -$48.00M | -$32.00M | $806.00M |
| Q4 2020Dec 31, 2020 | $297.00M | $220.00M | $266.00M | $63.00M | -$84.00M | $6.00M | $768.00M |
| Q3 2020Sep 30, 2020 | $162.00M | $350.00M | $195.00M | $46.00M | -$71.00M | -$12.00M | $670.00M |
| Q2 2020Jun 30, 2020 | $964.00M | $335.00M | $383.00M | $77.00M | -$65.00M | $27.00M | $1.72B |
| Q1 2020Mar 31, 2020 | $7.00M | $285.00M | $236.00M | $46.00M | -$66.00M | $0.00 | $508.00M |

